Tokyo, Japan

Yoshiyasu Shitori


Average Co-Inventor Count = 5.2

ph-index = 7

Forward Citations = 162(Granted Patents)


Location History:

  • Musashino, JP (1984 - 1990)
  • Tokyo, JP (1987 - 1992)

Company Filing History:


Years Active: 1984-1992

Loading Chart...
26 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Yoshiyasu Shitori

Introduction

Yoshiyasu Shitori, an esteemed inventor based in Tokyo, Japan, has made significant strides in the field of biotechnology, particularly in developing monoclonal antibodies. With a remarkable portfolio of 26 patents, his innovations have played a crucial role in advancing medical research and treatment.

Latest Patents

Shitori's impressive contributions include several notable patents. One of his latest innovations involves monoclonal antibodies that are specific for free N-acetylfuraminic acid. This groundbreaking work details the hybridoma process for producing monoclonal antibodies specific to free N-acetylneuraminic acid or its beta-glycoconjugates. The hybridoma is generated by fusing B cells obtained from immunizing an animal with N-acetylneuraminic acid and myeloma cells.

Additionally, he developed a hybridoma capable of producing monoclonal antibodies that specifically recognize sialic acid-containing glycolipids with N-acetylneuraminic acid residues having an alpha 2,3 linkage. This patent describes the fusion of B cells obtained by immunizing an animal with such glycolipids and myeloma cells, emphasizing its applications for purifying gangliosides, treating patients suffering from melanoma, and diagnosing sera.

Career Highlights

Throughout his career, Shitori has collaborated with notable organizations. He has worked with Mect Corporation and Kanto Ishi Pharmaceutical Co., Ltd., where he furthered his research and development in monoclonal antibodies and related fields.

Collaborations

Shitori has shared his expertise with talented colleagues, including Masayoshi Ito and Tomoya Ogawa. Their joint efforts have significantly contributed to advancements in their shared field, fostering innovation and teamwork.

Conclusion

Yoshiyasu Shitori is a prominent figure in the realm of biotechnology, whose 26 patents underscore his dedication to innovation and scientific advancement. His work on monoclonal antibodies holds the potential to make a lasting impact in medical research and treatment, showcasing the importance of collaboration among inventors and research institutions in pushing the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…